Health Condition 1: null- Patient having chronic spontaneous urticaria
Conditions
Interventions
Intervention1: Levocetrizine: patients will be treated with double the dose of levocetrizine i.e. 10mg/day and will be re-evaluated after 2 weeks by UCT (visit 4). Those who are not well-controlled, l
Sponsors
Self
Eligibility
Inclusion criteria
Inclusion criteria: a) Patients >18 years of age b) Patients fulfilling the definition of chronic spontaneous urticaria which is urticarial lesions occurring most days of the week (at least 3 times a week) lasting for 6 weeks or more with no identifiable cause on history or examination
Exclusion criteria
Exclusion criteria: 1. Patients not fulfilling the diagnosis of chronic spontaneous urticaria 2. Patients 3. Patients unwilling to participate in the study 4. Patients with physical urticaria, contact urticaria, drug-induced urticaria and urticarial vasculitis 5. Pregnant or breast-feeding female patients 6. Use of systemic steroids or other immunomodulators/immunosuppressants in the last 4 weeks; antihistamines in the last 7 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Proportion of patients achieving complete control of urticaria, as measured by urticaria control test (UCT)Timepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Proportion of patients achieving complete control of urticaria, as measured by urticaria control test (UCT)Timepoint: 7 weeks | — |
Countries
India
Contacts
Public ContactDr V K Sharma
All India Institute of Medical Science
Outcome results
None listed